{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:15:43Z","timestamp":1791249343197,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Interdisciplinary Clinical Research Project of Peking University First Hospital","award":["2021CR33"],"award-info":[{"award-number":["2021CR33"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>\n                      To investigate the diagnostic efficacy of\n                      <jats:sup>68<\/jats:sup>\n                      Ga-pentixafor positron emission tomography\/computed tomography (PET\/CT) in primary aldosteronism (PA) subtyping and lateralization of aldosterone secretion in PA patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Procedures<\/jats:title>\n                    <jats:p>\n                      37 patients who were diagnosed with PA, were prospectively enrolled in the study, and underwent adrenal vein sampling (AVS) after\n                      <jats:sup>68<\/jats:sup>\n                      Ga-pentixafor PET\/CT was conducted. Lateralization index (LI), defined as aldosterone\/cortisol ratio in the dominant side to the contralateral adrenal vein when bilateral adrenal vein catheterization succeeded, and the aldosterone\/cortisol ratio in the left adrenal vein to IVC (LAV\/IVC) when the catheterization of right adrenal vein failed, were applied to determine lateralization side. Statistical analysis was performed using SPSS 21.0.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The female proportion of all patients with PA was 32.4% (12\/37), and the mean age was 51.3\u2009\u00b1\u200910.9 years. Patients with bilateral adrenal mass accounted for 54.1% (20\/37), and 10 of them (27.0%) had adrenal hyperplasia or adrenal nodules\u2009\u2264\u20091.0 cm. In all 37 patients, the sensitivity, specificity and accuracy of\n                      <jats:sup>68<\/jats:sup>\n                      Ga-pentixafor PET\/CT in distinguishing lateralization by visualization were 89.3%, 77.8% and 86.5%, respectively. The area under the ROC curve for detecting positive lateralization based on the value of\n                      <jats:sup>68<\/jats:sup>\n                      Ga-pentixafor SUV\n                      <jats:sub>max<\/jats:sub>\n                      was 0.750 (95%CI 0.578\u20130.922,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.026). The optimum SUV\n                      <jats:sub>max<\/jats:sub>\n                      cut-off value was 6.86, with the sensitivity of 78.6%, specificity of 66.7%, and accuracy of 78.4%. Defining SUV ratio as SUV\n                      <jats:sub>max<\/jats:sub>\n                      \/SUV of contralateral adrenal gland, the area under the ROC curve for identifying lateralization based on the SUV ratio was 0.710 (95%CI 0.500\u20130.921,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.061). The optimum SUV ratio cut-off was 2.40, with the sensitivity of 60.7%, specificity of 88.9%, and accuracy of 67.6%. The consistency of\n                      <jats:sup>68<\/jats:sup>\n                      Ga-pentixafor PET\/CT with AVS was of no significant difference between patients with bilateral adrenal lesions (80.0%, 16\/20) and unilateral lesion (94.1%, 16\/17;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.737), and no significance was revealed in the consistency between patients with adrenal hyperplasia or adrenal lesion of diameter\u2009\u2264\u20091 cm (81.8%, 9\/11) and those with adrenal lesions\u2009&gt;\u20091 cm (88.5%, 23\/26;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.884).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:sup>68<\/jats:sup>\n                      Ga-pentixafor PET\/CT showed at least 80% consistency for the lateralization in patients with PA compared with AVS, even in those presented with bilateral adrenal hyperplasia. Visual analysis exhibited better diagnostic efficacy compared with SUV\n                      <jats:sub>max<\/jats:sub>\n                      or SUV\n                      <jats:sub>max<\/jats:sub>\n                      \/SUV of the contralateral adrenal gland.( ChiCTR2300073049. Registered 30 June 2023. Retrospectively registered)\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11307-024-01976-0","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T12:20:45Z","timestamp":1734956445000},"page":"142-150","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["68Ga-pentixafor PET\/CT Is a Supplementary Method for Primary Aldosteronism Subtyping Compared with Adrenal Vein Sampling"],"prefix":"10.1007","volume":"27","author":[{"given":"Tieci","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Difei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyu","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojiang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1305-3980","authenticated-orcid":false,"given":"Wei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"1976_CR1","doi-asserted-by":"crossref","unstructured":"Rossi GP, Bernini G, Caliumi C, et al; PAPY Study Investigators (2006) A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients. J Am Coll Cardiol 48(11): 2293\u20132300","DOI":"10.1016\/j.jacc.2006.07.059"},{"issue":"5","key":"1976_CR2","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"RM Carey","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F et al (2016) The management of primary aldosteronism\u202f: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101(5):1889\u20131916","journal-title":"J Clin Endocrinol Metab"},{"key":"1976_CR3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","volume":"5","author":"TA Williams","year":"2017","unstructured":"Williams TA, Lenders JWM, Mulatero P et al (2017) Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol 5:689\u2013699","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"1976_CR4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","volume":"151","author":"MJ Kempers","year":"2009","unstructured":"Kempers MJ, Lenders JWM, van Outheusden L et al (2009) Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism. Ann Intern Med 151(5):329\u2013337","journal-title":"Ann Intern Med"},{"key":"1976_CR5","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","volume":"136","author":"WF Young","year":"2004","unstructured":"Young WF, Stanson AW, Thompson GB et al (2004) Role for adrenal venous sampling in primary aldosteronism. Surgery 136:1227\u20131235","journal-title":"Surgery"},{"key":"1976_CR6","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1507\/endocrj.K07E-164","volume":"55","author":"I Minami","year":"2008","unstructured":"Minami I, Yoshimoto T, Hirono Y et al (2008) Diagnositc accuracy of adrenal venous sampling in comparison with other parameters in primary aldosteronism. Endocr J 55:839\u2013846","journal-title":"Endocr J"},{"key":"1976_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1001\/archsurg.141.5.497","volume":"141","author":"FE Nwariaku","year":"2006","unstructured":"Nwariaku FE, Miller BS, Auchus R et al (2006) Primary hyperaldosteronism: effect of adrenal vein sampling on surgical outcome. Arch Surg 141:497\u2013503","journal-title":"Arch Surg"},{"issue":"2","key":"1976_CR8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","volume":"71","author":"B Heinze","year":"2018","unstructured":"Heinze B, Fuss CT, Mulatero P et al (2018) Targeting CXCR4 (CXC chemokine receptor type 4) for molecular imaging of aldosterone-producing adenoma. Hypertension 71(2):317\u2013325","journal-title":"Hypertension"},{"issue":"2","key":"1976_CR9","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1007\/s00330-022-09058-x","volume":"33","author":"Y Gao","year":"2023","unstructured":"Gao Y, Ding J, Cui Y et al (2023) Functional nodules in primary aldesteronism: identification of CXCR4 expression with 68Ga-pentixafor PET\/CT. Eur Radiol 33(2):996\u20131003","journal-title":"Eur Radiol"},{"issue":"8","key":"1976_CR10","first-page":"2854","volume":"85","author":"KC Loh","year":"2000","unstructured":"Loh KC, Koay ES, Khaw MC et al (2000) Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 85(8):2854\u20132859","journal-title":"J Clin Endocrinol Metab"},{"key":"1976_CR11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.surg.2015.06.048","volume":"159","author":"JD Pasternak","year":"2016","unstructured":"Pasternak JD, Epelboym I, Seiser N et al (2016) Diagnostic utility of data from adrenal venous sampling for primary aldosteronism despite failed cannulation of the right adrenal vein. Surgery 159:267\u2013274","journal-title":"Surgery"},{"issue":"11","key":"1976_CR12","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1007\/s00259-020-04722-0","volume":"47","author":"J Ding","year":"2020","unstructured":"Ding J, Zhang Y, Wen J et al (2020) Imaging CXCR4 expression in patients with suspected primary hyperaldesteronism. Eur J Nucl Med Mol Imaging 47(11):2656\u20132665","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"1976_CR13","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s41574-022-00730-2","volume":"18","author":"AF Turcu","year":"2022","unstructured":"Turcu AF, Yang J, Vaidya A (2022) Primary aldosteronism \u2013 a multidimensional syndrome. Nat Rev Endocrinol 18(11):665\u2013682","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"1976_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s42155-021-00220-y","volume":"4","author":"KB Quencer","year":"2021","unstructured":"Quencer KB (2021) Adrenal vein sampling: technique and protocol, a systematic review. CVIR Endovasc 4(1):38","journal-title":"CVIR Endovasc"},{"issue":"11","key":"1976_CR15","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1097\/HJH.0000000000001855","volume":"36","author":"H Kobayashi","year":"2018","unstructured":"Kobayashi H, Abe M, Soma M et al (2018) Development and validation of subtype prediction scores for the workup of primary aldosteronism. J Hypertens 36(11):2269\u20132276","journal-title":"J Hypertens"},{"issue":"3","key":"1976_CR16","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1210\/jc.2011-2384","volume":"97","author":"P Mulatero","year":"2012","unstructured":"Mulatero P, di Cella SM, Monticone S et al (2012) 18-hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes. J Clin Endocrinol Metab 97(3):881\u2013889","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1976_CR17","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1210\/jc.2014-3551","volume":"100","author":"Y Jiang","year":"2015","unstructured":"Jiang Y, Zhang C, Wang W et al (2015) Diagnostic value of ACTH stimulating test in determining the subtypes of primary aldosteronism. J Clin Endocrinol Metab 100(5):1837\u20131844","journal-title":"J Clin Endocrinol Metab"},{"key":"1976_CR18","doi-asserted-by":"publisher","first-page":"e837","DOI":"10.1210\/clinem\/dgad451","volume":"109","author":"E Ng","year":"2024","unstructured":"Ng E, Gwini SM, Zheng W et al (2024) Predicting bilateral subtypes of primary aldosteronism without adrenal vein sampling: a systematic review and meta-analysis. J Clin Endocrinol Metab 109:e837\u2013e855","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1976_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1210\/clinem\/dgad421","volume":"109","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Long T, Peng N et al (2023) The value of targeting CXCR4 with 68Ga-pentixafor PET\/CT for subtyping primary aldosteronism. J Ciln Endocrinol Metab 109(1):171\u2013182","journal-title":"J Ciln Endocrinol Metab"},{"key":"1976_CR20","doi-asserted-by":"publisher","first-page":"1291775","DOI":"10.3389\/fendo.2024.1291775","volume":"15","author":"X Yin","year":"2024","unstructured":"Yin X, Ai K, Luo J et al (2024) A comparison of the performance of 68Ga-pentixafor PET\/CT versus adrenal vein sampling for subtype diagnosis in primary aldosteronism. Front Endocrinol (Lausanne) 15:1291775","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-024-01976-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-024-01976-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-024-01976-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T10:52:44Z","timestamp":1738925564000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-024-01976-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1976"],"URL":"https:\/\/doi.org\/10.1007\/s11307-024-01976-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4889756\/v1","asserted-by":"object"}]},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]},"assertion":[{"value":"25 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The clinical institutional review board approved this study (No.2021\u2013461).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}